TCM

TCG Crossover Management Portfolio holdings

AUM $876M
1-Year Est. Return 23.66%
This Quarter Est. Return
1 Year Est. Return
+23.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.26B
AUM Growth
+$363M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$157M
2
+$74.3M
3
+$58.2M
4
OCUL icon
Ocular Therapeutix
OCUL
+$48.4M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$41.5M

Top Sells

1
+$58.4M
2
+$54.1M
3
+$45.3M
4
KALV icon
KalVista Pharmaceuticals
KALV
+$26.5M
5
GPCR icon
Structure Therapeutics
GPCR
+$21.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$157M 12.39%
+3,570,206
2
$75.2M 5.95%
2,650,150
+1,000,000
3
$74.3M 5.87%
+5,278,928
4
$71.2M 5.63%
3,295,350
+1,190,475
5
$68.5M 5.42%
1,598,421
-511,163
6
$65.1M 5.15%
62,894
7
$61.2M 4.84%
1,750,387
8
$58.2M 4.6%
+879,344
9
$57.4M 4.54%
17,391,639
-5,984,200
10
$49.8M 3.94%
10,000,000
11
$48.4M 3.83%
+5,319,148
12
$41.8M 3.3%
6,214,375
+583,333
13
$41.5M 3.28%
+2,272,728
14
$41.1M 3.25%
+3,185,185
15
$39.9M 3.15%
149,283
-30,634
16
$33.8M 2.68%
1,477,593
+469,691
17
$32.6M 2.58%
1,989,103
18
$32.1M 2.54%
3,858,000
19
$30.4M 2.4%
1,423,642
20
$28.9M 2.28%
793,829
-349,028
21
$28.4M 2.25%
+2,008,340
22
$23.5M 1.86%
+550,000
23
$23.1M 1.82%
2,040,816
24
$15.7M 1.24%
1,100,000
25
$14.1M 1.12%
2,676,580
1
2